Lynparza 150 mg/1 (Olaparib TABLET, FILM COATED) 150 mg/1

Lynparza 150 mg is a medication used in cancer treatment. It contains olaparib, a PARP inhibitor, and is available in film-coated tablet form. This drug is commonly prescribed for specific types of cancer, including ovarian and breast cancer.

Strength

150 mg/1

Pack Size

60 TABLET, FILM COATED in 1 BOTTLE (0310-0679-95)

Manufacturer / TM Owner

AstraZeneca Pharmaceuticals LP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Lynparza 150 mg is primarily used in the treatment of certain types of cancer. It is often prescribed for patients with ovarian cancer who have a specific genetic mutation. Additionally, it may be used in the treatment of breast cancer in patients with a BRCA mutation. The medication works by targeting and inhibiting an enzyme involved in DNA repair, which can help slow the growth of cancer cells.

Side Effects

Common effects of Lynparza 150 mg may include fatigue, nausea, and vomiting. Some patients may also experience anemia, which can cause weakness and shortness of breath. It is important to discuss any side effects with a healthcare provider to ensure proper management.

Precautions & Warnings

Lynparza 150 mg should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions.

Avoid Interactions

Lynparza 150 mg may interact with certain medications, including those that affect liver enzymes. It is important to discuss all current medications with a healthcare provider before starting Lynparza. Additionally, alcohol and other substances may affect the efficacy of the medication.

Frequently Asked Questions

Lynparza 150 mg is used in the treatment of certain types of cancer, particularly ovarian and breast cancer in patients with specific genetic mutations.

Lynparza 150 mg should be taken orally, following the dosage and administration instructions provided by a healthcare professional.

Common side effects of Lynparza 150 mg include fatigue, nausea, vomiting, and anemia.

It is important to discuss all current medications with a healthcare provider before starting Lynparza 150 mg to avoid potential interactions.

Lynparza 150 mg should be handled with care and stored as directed. Follow the prescribed dosage and administration instructions provided by a healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.